Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Private Placement [Member]	Preferred Stock [Member] Series A-1 Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member] Private Placement [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Private Placement [Member]	Additional Paid-in Capital [Member] Series A-1 Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Private Placement [Member]	Retained Earnings [Member] Series A-1 Preferred Stock [Member]	Retained Earnings [Member]	Private Placement [Member]	Series A-1 Preferred Stock [Member]	Total
Balance (in shares) at Dec. 31, 2022			60,961		522,177
Balance at Dec. 31, 2022			$ 0		$ 8			$ 406,514			$ (402,376)			$ 4,146
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares)			0		607,236
Issuance of common stock in public offerings, net of commissions and issuance costs			$ 0		$ 1			5,173			0			5,174
Conversion of CRG loan principal into Series E convertible preferred stock (in shares)			1,920		0
Conversion of CRG loan principal into Series E convertible preferred stock			$ 0		$ 0			1,920			0			1,920
Employee stock-based compensation			$ 0		$ 0			703			0			703
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares (in shares)			0		56,896
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares			$ 0		$ (9)			9			0			0
Net and comprehensive loss											(13,296)			(13,296)
Exercises of pre-funded warrants for common stock (in shares)			0		91,325
Exercises of pre-funded warrants for common stock			$ 0		$ 1			(2)			0			(1)
Issuance of common stock upon vesting of restricted stock units (in shares)			0		2,294
Issuance of common stock upon vesting of restricted stock units			$ 0		$ 0			0			0			0
Net Income (Loss) Attributable to Parent											(13,296)			(13,296)
Balance (in shares) at Sep. 30, 2023			62,881		1,279,928
Balance at Sep. 30, 2023			$ 0		$ 1			414,317			(415,672)			(1,354)
Balance (in shares) at Dec. 31, 2022			60,961		522,177
Balance at Dec. 31, 2022			$ 0		$ 8			406,514			(402,376)			4,146
Balance (in shares) at Dec. 31, 2023			62,881		1,279,928
Balance at Dec. 31, 2023			$ 0		$ 1			414,493			(420,696)			(6,202)
Balance (in shares) at Jun. 30, 2023			60,961		622,578
Balance at Jun. 30, 2023			$ 0		$ 9			404,597			(411,196)			(6,590)
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares)			0		600,454
Issuance of common stock in public offerings, net of commissions and issuance costs			$ 0		$ 1			5,136			0			5,137
Conversion of CRG loan principal into Series E convertible preferred stock (in shares)			1,920		0
Conversion of CRG loan principal into Series E convertible preferred stock			$ 0		$ 0			1,920			0			1,920
Employee stock-based compensation			$ 0		$ 0			219			0			219
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares (in shares)			0		56,896
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares			$ 0		$ (9)			9			0			0
Waiver of Series A preferred stock dividends			0		0			2,436			0			2,436
Net and comprehensive loss			0		0			0			(4,476)			(4,476)
Net Income (Loss) Attributable to Parent			$ 0		$ 0			0			(4,476)			(4,476)
Balance (in shares) at Sep. 30, 2023			62,881		1,279,928
Balance at Sep. 30, 2023			$ 0		$ 1			414,317			(415,672)			(1,354)
Balance (in shares) at Dec. 31, 2023			62,881		1,279,928
Balance at Dec. 31, 2023			$ 0		$ 1			414,493			(420,696)			(6,202)
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares)	7,224	10,000	0	75,327	330,000
Issuance of common stock in public offerings, net of commissions and issuance costs	$ 0	$ 0	$ 0	$ 0	$ 0	$ 6,880	$ 0	5,155	$ 0	$ 0	0	$ 6,880	$ 0	5,155
Conversion of CRG loan principal into Series E convertible preferred stock (in shares)			11,000		0
Conversion of CRG loan principal into Series E convertible preferred stock			$ 0		$ 0			11,000			0			11,000
Employee stock-based compensation			0		0			1,525			0			1,525
Net and comprehensive loss			$ 0		$ 0			0			(13,585)			(13,585)
Exercises of pre-funded warrants for common stock (in shares)			0		867,457
Exercises of pre-funded warrants for common stock			$ 0		$ 1			0			0			1
Accretion of preferred stock dividends			0		0			(652)			0			(652)
Net Income (Loss) Attributable to Parent			$ 0		$ 0			0			(13,585)			(13,585)
Issuance of common stock warrants in connection with the Private Placement (in shares)			0		0
Issuance of common stock warrants in connection with the Private Placement			$ 0		$ 0			127			0			127
Issuance of common stock warrants in connection with the Private Placement			$ 0		$ 0			127			0			127
Cancellation of Series A preferred stock (in shares)			(60,876)		0
Cancellation of Series A preferred stock			$ 0		$ 0			0			0			0
Issuance of common stock upon vesting of restricted stock awards (in shares)			0		368,503
Issuance of common stock upon vesting of restricted stock awards			$ 0		$ 1			0			0			1
Net share settlement of restricted stock awards in satisfaction of tax obligations (in shares)			0		(137,324)
Net share settlement of restricted stock awards in satisfaction of tax obligations			$ 0		$ 0			(374)			0			(374)
Balance (in shares) at Sep. 30, 2024			30,229		2,783,891
Balance at Sep. 30, 2024			$ 0		$ 3			438,153			(434,281)			3,875
Balance (in shares) at Jun. 30, 2024			30,229		1,916,434
Balance at Jun. 30, 2024			$ 0		$ 2			438,326			(430,575)			7,753
Conversion of CRG loan principal into Series E convertible preferred stock (in shares)			0		0
Conversion of CRG loan principal into Series E convertible preferred stock			$ 0		$ 0			0			0			0
Employee stock-based compensation			0		0			222			0			222
Net and comprehensive loss			0		0			0			(3,706)			(3,706)
Issuance of common stock in public offerings, net of commissions and issuance costs			$ 0		$ 0			(45)			0			(45)
Exercises of pre-funded warrants for common stock (in shares)			0		867,457
Exercises of pre-funded warrants for common stock			$ 0		$ 1			0			0			1
Accretion of preferred stock dividends			0		0			(349)			0			(349)
Net Income (Loss) Attributable to Parent			$ 0		$ 0			0			(3,706)			(3,706)
Balance (in shares) at Sep. 30, 2024			30,229		2,783,891
Balance at Sep. 30, 2024			$ 0		$ 3			$ 438,153			$ (434,281)			$ 3,875